Clinical Studies Sponsored by Synlogic

Clinical Studies Sponsored by Synlogic

Clinical Studies Sponsored by ResMed

Clinical Studies Sponsored by argenx

Clinical Studies Sponsored by University of Minnesota

Accounts payable venture capital investors

List of AI property insurance companies

Clinical Studies where

Trial Sponsor

is

	Name	Description	NCT Number	Health Conditions in Trial	Clinical Trial Start Date	Study Completion Date	Clinical Trial Study Type
	‌ Safety and Tolerability of SYNB1618 in Healthy Adult Volunteers and Adult Subjects With Phenylketonuria		NCT03516487	Phenylketonuria ‌ Healthy	April 17, 2018	June 21, 2019	Interventional
	‌ Safety and Tolerability of SYNB1934 in Healthy Adult Volunteers		NCT04984525	‌ Healthy	July 2, 2021	December 10, 2021	Interventional
	‌ Safety, Tolerability and Pharmacodynamics of SYNB1020		NCT03447730	Cirrhosis	March 19, 2018	July 19, 2019	Interventional
	‌ Efficacy and Safety of SYNB1618 and SYNB1934 in Adult Patients With Phenylketonuria		NCT04534842	Phenylketonuria	August 25, 2020	October 7, 2022	Interventional
	‌ Safety and Tolerability of SYNB1891 Injection Alone or in Combination With Atezolizumab in Adult Subjects		NCT04167137	Lymphoma	November 1, 2019	June 17, 2023	Interventional
	‌ Safety and Tolerability of SYNB8802 in Healthy Adult Volunteers and Adult Subjects With Enteric Hyperoxaluria		NCT04629170	‌ Healthy	November 4, 2020	September 13, 2021	Interventional
	‌ Safety, Tolerability, and Pharmacodynamics of SYNB8802v1 in Subjects With History of Gastric Bypass Surgery or Short-bowel Syndrome		NCT05377112		March 29, 2022	December 7, 2022	Interventional
	‌ Safety, Tolerability and Pharmacodynamics of SYNB1353 in Healthy Adult Volunteers		NCT05462132	Homocystinuria	July 7, 2022	November 27, 2022	Interventional
	‌ Safety and Tolerability of SYNB1020-CP-001		NCT03179878		June 16, 2017	April 11, 2018	Interventional

9 results

0 selected

9 results

0 selected